Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study

BACKGROUND: The development of cancer has been associated with epigenetic alterations such as aberrant histone deacetylase (HDAC) activity. It was recently reported that valproic acid is an effective inhibitor of histone deacetylases and as such induces tumor cell differentiation, apoptosis, or grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez-Blanco, Alma, Segura-Pacheco, Blanca, Perez-Cardenas, Enrique, Taja-Chayeb, Lucia, Cetina, Lucely, Candelaria, Myrna, Cantu, David, Gonzalez-Fierro, Aurora, Garcia-Lopez, Patricia, Zambrano, Pilar, Perez-Plasencia, Carlos, Cabrera, Gustavo, Trejo-Becerril, Catalina, Angeles, Enrique, Duenas-Gonzalez, Alfonso
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1198251/
https://www.ncbi.nlm.nih.gov/pubmed/16001982
http://dx.doi.org/10.1186/1476-4598-4-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1198251/
https://www.ncbi.nlm.nih.gov/pubmed/16001982
http://dx.doi.org/10.1186/1476-4598-4-22

Ejemplares similares